Speciality: Oncology
Description:
Dr. Srinivas K G presents a compelling retrospective analysis titled "ESMO Breast Cancer 2022: P REALITY X" in this insightful video. The discussion delves into the real-world efficacy and clinical outcomes of a specific breast cancer treatment regimen, as examined during the ESMO Breast Cancer 2022 conference. Dr. Srinivas meticulously reviews the data, highlighting key findings, patient responses, and the implications for future therapeutic strategies. His expertise provides valuable perspectives for oncologists and researchers seeking to optimize breast cancer management.
The video explores the retrospective study design, patient demographics, and survival outcomes analyzed in the P REALITY X trial. Dr. Srinivas emphasizes the importance of real-world evidence in complementing randomized clinical trials, offering a more comprehensive understanding of treatment effectiveness in diverse populations. He also addresses potential limitations and biases inherent in retrospective analyses, ensuring a balanced interpretation of the results. This session is a must-watch for medical professionals aiming to stay updated on the latest advancements in breast cancer research.
Dr. Srinivas K G’s detailed breakdown of the P REALITY X study serves as an invaluable resource for the oncology community. By bridging the gap between clinical trials and real-world practice, his analysis fosters a deeper appreciation for evidence-based decision-making. Stay tuned for more expert discussions and cutting-edge insights in upcoming videos. Your journey towards mastering breast cancer therapeutics continues here!
See More Webinars @ Hidoc Webinars
1.
Report reveals lung cancer is the leading cause of cancer deaths in Florida
2.
Prostate cancer early detection system eliminates need for biopsy.
3.
Infection tied to one-fourth of deaths with lower-risk myelodysplastic syndromes
4.
November 2023, Medical Bulletin 04/.
5.
For fit patients with CLL, frontline venetoclax-ibrutinib improves survival.
1.
Screening Strategies in Oncology: A Subspecialty Guide to Early Detection and Better Outcomes
2.
Understanding the HAS-BLED Score: What It Is and Why It Matters
3.
Autophagy: A Double-Edged Sword in Cancer Development, Immune Evasion, and Drug Resistance
4.
Precision Medicine and Genomics: Revolutionizing Healthcare Through Personalized Treatment
5.
Bridging the Gap Between Cancer Treatment-Induced Cardiotoxicity and Regenerative Medicine
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
2.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part II
4.
ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation